179 related articles for article (PubMed ID: 32573008)
1. Exploration of dual fatty acid amide hydrolase and cholinesterase inhibitory potential of some 3-hydroxy-3-phenacyloxindole analogs.
Tripathi RKP; Ayyannan SR
Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000036. PubMed ID: 32573008
[TBL] [Abstract][Full Text] [Related]
2. Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches.
Zafar R; Naureen H; Zubair M; Shahid K; Saeed Jan M; Akhtar S; Ahmad H; Waseem W; Haider A; Ali S; Tariq M; Sadiq A
Drug Des Devel Ther; 2021; 15():2679-2694. PubMed ID: 34188447
[TBL] [Abstract][Full Text] [Related]
3. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
[TBL] [Abstract][Full Text] [Related]
4. Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's disease.
Kurt BZ; Gazioglu I; Basile L; Sonmez F; Ginex T; Kucukislamoglu M; Guccione S
Eur J Med Chem; 2015 Sep; 102():80-92. PubMed ID: 26244990
[TBL] [Abstract][Full Text] [Related]
5. New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease.
Chufarova N; Czarnecka K; Skibiński R; Cuchra M; Majsterek I; Szymański P
Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800050. PubMed ID: 29870588
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, molecular modeling and cholinesterase inhibitory effects of 2-indolinone-based hydrazinecarbothioamides.
Demir-Yazıcı K; Apaydın ÇB; Soylu-Eter Ö; Özsoy N; Karalı N
Future Med Chem; 2021 Dec; 13(24):2133-2151. PubMed ID: 34755546
[No Abstract] [Full Text] [Related]
7. Search for new multi-target compounds against Alzheimer's disease among histamine H
Bajda M; Łażewska D; Godyń J; Zaręba P; Kuder K; Hagenow S; Łątka K; Stawarska E; Stark H; Kieć-Kononowicz K; Malawska B
Eur J Med Chem; 2020 Jan; 185():111785. PubMed ID: 31669851
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of new carbamates as inhibitors for fatty acid amide hydrolase and cholinesterases: Molecular dynamic, in vitro and in vivo studies.
Maleki MF; Nadri H; Kianfar M; Edraki N; Eisvand F; Ghodsi R; Mohajeri SA; Hadizadeh F
Bioorg Chem; 2021 Apr; 109():104684. PubMed ID: 33607363
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis and Biological Evaluation of Xanthone Derivatives for Possible Treatment of Alzheimer's Disease Based on Multi-Target Strategy.
Yang A; Yu Q; Ju H; Song L; Kou X; Shen R
Chem Biodivers; 2020 Oct; 17(10):e2000442. PubMed ID: 32692899
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.
Yu YF; Huang YD; Zhang C; Wu XN; Zhou Q; Wu D; Wu Y; Luo HB
ACS Chem Neurosci; 2017 Nov; 8(11):2522-2534. PubMed ID: 28783948
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel dual-active 3-(4-(dimethylamino)phenyl)-7-aminoalcoxy-coumarin as potent and selective acetylcholinesterase inhibitor and antioxidant.
de Souza GA; da Silva SJ; Del Cistia CN; Pitasse-Santos P; Pires LO; Passos YM; Cordeiro Y; Cardoso CM; Castro RN; Sant'Anna CMR; Kümmerle AE
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):631-637. PubMed ID: 30727776
[TBL] [Abstract][Full Text] [Related]
14. Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents.
Montanari S; Scalvini L; Bartolini M; Belluti F; Gobbi S; Andrisano V; Ligresti A; Di Marzo V; Rivara S; Mor M; Bisi A; Rampa A
J Med Chem; 2016 Jul; 59(13):6387-406. PubMed ID: 27309570
[TBL] [Abstract][Full Text] [Related]
15. Novel Cyclopentaquinoline and Acridine Analogs as Multifunctional, Potent Drug Candidates in Alzheimer's Disease.
Maciejewska K; Czarnecka K; Kręcisz P; Niedziałek D; Wieczorek G; Skibiński R; Szymański P
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682556
[TBL] [Abstract][Full Text] [Related]
16. Graveoline Analogs Exhibiting Selective Acetylcholinesterase Inhibitory Activity as Potential Lead Compounds for the Treatment of Alzheimer's Disease.
Li Z; Mu C; Wang B; Jin J
Molecules; 2016 Jan; 21(2):132. PubMed ID: 26805806
[TBL] [Abstract][Full Text] [Related]
17. Exploiting the Chalcone Scaffold to Develop Multifunctional Agents for Alzheimer's Disease.
Rampa A; Bartolini M; Pruccoli L; Naldi M; Iriepa I; Moraleda I; Belluti F; Gobbi S; Tarozzi A; Bisi A
Molecules; 2018 Jul; 23(8):. PubMed ID: 30061534
[TBL] [Abstract][Full Text] [Related]
18. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation.
Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Rudakova EV; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
Bioorg Chem; 2020 Jan; 94():103387. PubMed ID: 31735356
[TBL] [Abstract][Full Text] [Related]
19. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
Li Y; Qiang X; Li Y; Yang X; Luo L; Xiao G; Cao Z; Tan Z; Deng Y
Bioorg Med Chem Lett; 2016 Apr; 26(8):2035-9. PubMed ID: 26947607
[TBL] [Abstract][Full Text] [Related]
20. Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents.
Maqbool M; Manral A; Jameel E; Kumar J; Saini V; Shandilya A; Tiwari M; Hoda N; Jayaram B
Bioorg Med Chem; 2016 Jun; 24(12):2777-88. PubMed ID: 27157006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
